These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 19753731)

  • 41. [Nucleolar organizer regions and mitotic activity in non-Hodgkin's lymphoma].
    Dubrovskiĭ ACh; Kliukina LB
    Arkh Patol; 1997; 59(1):25-30. PubMed ID: 9139602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Higher reproducibility of morphometric analysis over the counting method for interphase AgNOR quantification.
    Trerè D; Migaldi M; Trentini GP
    Anal Cell Pathol; 1995 Jan; 8(1):57-65. PubMed ID: 7734412
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of argyrophilic nucleolar organizer regions by counting and image analysis in canine mammary tumors.
    Destexhe E; Vanmanshoven P; Coignoul F
    Am J Vet Res; 1995 Feb; 56(2):185-7. PubMed ID: 7717583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nuclear morphometry and AgNOR quantification: computerized image analysis on ovarian mucinous tumor imprints.
    Versa-Ostojić D; Stanković T; Stemberger-Papić S; Vrdoljak-Mozetic D; Manestar M; Krasević M
    Anal Quant Cytol Histol; 2008 Jun; 30(3):160-8. PubMed ID: 18630841
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sequential quantification of AgNOR area and number during silver staining by means of an image analysing system.
    Ofner D; Hittmair A; Maier H; Riedmann B; Rumer A; Lucciarini P; Offner F; Mikuz G; Schmid KW
    Zentralbl Pathol; 1994 Mar; 140(1):37-40. PubMed ID: 7515671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Nucleolar organizer as a marker of malignancy grade and prognosis of non-Hodgkin's malignant lymphoma].
    Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Tupitsyn NN; Sholokhova EN
    Arkh Patol; 1996; 58(4):22-8. PubMed ID: 8967858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Argyrophilic nucleolar organizer regions in benign and malignant mesothelial lesions.
    Vacharadze K; Burkadze G; Turashvili G; Kiria N
    Georgian Med News; 2005 Nov; (128):91-3. PubMed ID: 16369075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Agnor as a marker of malignant transformation in odontogenic keratocysts.
    Piloni MJ; Keszler A; Itoiz ME
    Acta Odontol Latinoam; 2005; 18(1):37-42. PubMed ID: 16302459
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative evaluation of AgNORs in bone tumours.
    Arora B; Jindal K; Kumar S; Rekhi B; Arora H; Arora DR
    Pathology; 2003 Apr; 35(2):106-8. PubMed ID: 12745456
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Location of nucleolar organizer regions (AgNORs) in the nuclei of astrocytic tumors.
    Pedal WP; Warzok RW; Hufnagl P; Roth K
    Clin Neuropathol; 1995; 14(1):55-61. PubMed ID: 7729083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of nucleolar organizer regions in maxillary osteosarcoma.
    Paparella ML; Brandizzi D; Santini-Araujo E; Cabrini RL
    Acta Odontol Latinoam; 2007; 20(1):55-60. PubMed ID: 18046971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Morphometric analysis of nucleolar organizer regions in benign and malignant peritoneal effusions using backscattered electron microscopy.
    Lim SM; Duggan MA; Ruff M; Rahim S; McGregor SE; Green FH
    J Pathol; 1992 Jan; 166(1):53-60. PubMed ID: 1538274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatocellular carcinoma and preneoplastic lesions of the liver: evaluation of argyrophilic nucleolar organizer regions (AgNORs).
    Bufo P; Frassanito F
    Boll Soc Ital Biol Sper; 1992 Nov; 68(11):707-14. PubMed ID: 1338418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. AgNOR quantification with special reference to staining patterns.
    Rüschoff J; Fauser G; Knüchel R; Hofstädter F
    Zentralbl Pathol; 1994 Mar; 140(1):23-30. PubMed ID: 7515669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proliferative activity of esophageal carcinomas and their lymph node metastases: comparison using argyrophilic nucleolar organizer region staining.
    Yano K; Okamura T; Yoshida Y; Ichiyoshi Y; Yasumoto K
    J Surg Oncol; 1997 Aug; 65(4):274-9. PubMed ID: 9274793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Morphometric analysis of AgNORs in nonkeratinizing carcinoma and adjacent normal epithelia in the nasopharynx.
    Chen M; Lee JC; Wu X; Lo S
    Anal Quant Cytol Histol; 2002 Jun; 24(3):173-7. PubMed ID: 12102130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Video image analysis of AgNOR distribution in the normal and adenomatous colorectum.
    Weeks SC; Beroukas D; Jarvis LR; Whitehead R
    J Pathol; 1992 Feb; 166(2):139-45. PubMed ID: 1560314
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AgNOR and breast cancer. A study by image analysis.
    Ronco A; Larran J; López A; Vilches J
    Histol Histopathol; 1994 Apr; 9(2):309-13. PubMed ID: 8075491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
    Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
    Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Manual and automated AgNOR count in differentiating reactive mesothelial from metastatic malignant cells in serous effusions.
    Mohanty SK; Dey P; Rana P
    Anal Quant Cytol Histol; 2003 Oct; 25(5):273-6. PubMed ID: 14603724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.